Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice
Open Access
- 30 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 39 (2), 422-432
- https://doi.org/10.1002/hep.20045
Abstract
Hepatic ischemia/reperfusion (I/R) injury associated with liver transplantation and hepatic resection is characterized by hepatocellular damage and a deleterious inflammatory response. In this study, we examined whether receptor for advanced glycation end product (RAGE) activation is linked to mechanisms accentuating inflammation on I/R in a murine model of total hepatic ischemia. Animals treated with soluble RAGE (sRAGE), the extracellular ligand‐binding domain of RAGE, displayed increased survival after total hepatic I/R compared with vehicle treatment. TUNEL assay and histologic analysis revealed that blockade of RAGE was highly protective against hepatocellular death and necrosis on I/R; in parallel, proliferating cell nuclear antigen was enhanced in livers of mice treated with sRAGE. Rapid activation of p38, p44/42, stress‐activated protein kinase and c‐Jun N‐terminal kinase mitogen‐activated protein kinases, signal transducer and activator of transcription‐3, and nuclear translocation of activator protein‐1 was evident at early times on I/R. In the remnants of sRAGE‐treated livers, however, activation of each of these signaling and transcription factor pathways was strikingly decreased. sRAGE‐treated remnants displayed enhanced activation of nuclear factor κB, in parallel with increased transcripts for the proregenerative cytokine, tumor necrosis factor‐α. In conclusion, these data suggest that RAGE modulates hepatic I/R injury, at least in part by activation of key signaling pathways linked to proinflammatory and cell death‐promoting responses. We propose that blockade of this pathway may represent a novel strategy to attenuate injury in hepatic I/R and to facilitate regeneration. (HEPATOLOGY 2004;39:422–432.)Keywords
This publication has 36 references indexed in Scilit:
- Liver Protection from Apoptosis Requires Both Blockage of Initiator Caspase Activities and Inhibition of ASK1/JNK Pathway via Glutathione S-Transferase RegulationJournal of Biological Chemistry, 2002
- Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cellsHepatology, 2002
- Intermittent ischemia reduces warm hypoxia-reoxygenation–induced JNK1/SAPK1 activation and apoptosis in rat hepatocytesHepatology, 2001
- Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis?Hepatology, 2001
- Regulation of Liver Inflammatory Injury by Signal Transducer and Activator of Transcription-6The American Journal of Pathology, 2000
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liverHepatology, 1999
- Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor ?B independently of I?B degradationHepatology, 1998
- NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.JCI Insight, 1998
- INHIBITION OF NF-KB ACTIVATION BY DIMETHYL SULFOXIDE CORRELATES WITH SUPPRESSION OF TNF-α FORMATION, REDUCED ICAM-1 GENE TRANSCRIPTION, AND PROTECTION AGAINST ENDOTOXIN-INDUCED LIVER INJURYShock, 1997